NIKOLA TRBOVIC

Nikola Trbovic is currently a Partner at Pfizer Venture Investments, where he leads biotechnology investment decisions and portfolio company support across multiple therapeutic areas. Before assuming his current position, he served as an Associate Principal in the Pharmaceuticals Practice at McKinsey & Company, advising global healthcare clients on corporate finance and commercial strategy. He also brings experience from his time at SV Health Investors and his work managing early clinical portfolio decisions within Pfizer's broader corporate research and development organization. As part of an expanded team managing a $600 million venture commitment, he recently co-led a $120 million Series D funding round for Artios Pharma in November 2025. Trbovic leverages his PhD and extensive consulting background to identify and scale early-stage companies developing transformative medicines, with a particular emphasis on neuroscience chemistry and pharmacology.